Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Clin Chem Lab Med ; 55(1): 73-81, 2017 Jan 01.
Article in English | MEDLINE | ID: mdl-27341562

ABSTRACT

BACKGROUND: Dipeptidyl peptidase IV (DPPIV/CD26) plays an important role in T cell activation and immune regulation, however the role of this enzyme in early rheumatoid arthritis (eRA) has not been clearly defined. The aim of this study was to determine the serum activity of DPPIV, its expression on peripheral blood mononuclear cells (PBMC) and to examine possible correlations with disease activity (DAS28) in untreated patients with eRA. METHODS: The study included 50 patients newly diagnosed with RA, who had not received any corticosteroid or disease modifying antirheumatic drugs (DMARD) therapy and whose conventional radiographs of hands and feet showed no structural damage. The control group consisted of 40 healthy volunteers. Also, 30 patients with chronic RA (cRA) were examined. The serum activity of DPPIV was determined by the direct photometric method, while expression of CD26 on PBMC was determined using flow cytometry. RESULTS: Decreased DPPIV serum activity was detected in patients with eRA and cRA compared to the control group (p=0.024, p<0.0001, respectively). Although, the percentage of overall CD26+ white blood cells (WBC) was significantly decreased in eRA patients (p<0.001), the percentage of CD26+ lymphocytes and monocytes and mean fluorescence intensity of CD26 on these cells in eRA patients showed no significant difference compared to healthy volunteers. DAS28 showed no significant correlation with CD26 expression or DPPIV serum activity, but a significant inverse correlation between the duration of symptoms and DPPIV serum activity was observed. CONCLUSIONS: Our results show that a decrease in DPPIV serum activity, but not CD26 expression, is present in an early stage of rheumatoid arthritis.


Subject(s)
Arthritis, Rheumatoid/metabolism , Dipeptidyl Peptidase 4/metabolism , Leukocytes, Mononuclear/metabolism , Adult , Aged , Aged, 80 and over , Antirheumatic Agents/therapeutic use , Arthritis, Rheumatoid/diagnosis , Arthritis, Rheumatoid/drug therapy , Dipeptidyl Peptidase 4/biosynthesis , Dipeptidyl Peptidase 4/blood , Female , Flow Cytometry , Humans , Leukocytes, Mononuclear/pathology , Male , Middle Aged , Photometry , Young Adult
2.
Waste Manag ; 48: 619-629, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26706748

ABSTRACT

This study reports on the use of oil obtained from waste plum stones as a low-cost feedstock for biodiesel production. Because of high free fatty acid (FFA) level (15.8%), the oil was processed through the two-step process including esterification of FFA and methanolysis of the esterified oil catalyzed by H2SO4 and CaO, respectively. Esterification was optimized by response surface methodology combined with a central composite design. The second-order polynomial equation predicted the lowest acid value of 0.53mgKOH/g under the following optimal reaction conditions: the methanol:oil molar ratio of 8.5:1, the catalyst amount of 2% and the reaction temperature of 45°C. The predicted acid value agreed with the experimental acid value (0.47mgKOH/g). The kinetics of FFA esterification was described by the irreversible pseudo first-order reaction rate law. The apparent kinetic constant was correlated with the initial methanol and catalyst concentrations and reaction temperature. The activation energy of the esterification reaction slightly decreased from 13.23 to 11.55kJ/mol with increasing the catalyst concentration from 0.049 to 0.172mol/dm(3). In the second step, the esterified oil reacted with methanol (methanol:oil molar ratio of 9:1) in the presence of CaO (5% to the oil mass) at 60°C. The properties of the obtained biodiesel were within the EN 14214 standard limits. Hence, waste plum stones might be valuable raw material for obtaining fatty oil for the use as alternative feedstock in biodiesel production.


Subject(s)
Biofuels , Plant Oils/chemistry , Prunus domestica/chemistry , Seeds/chemistry , Technology/methods , Catalysis , Energy-Generating Resources , Esterification , Fatty Acids, Nonesterified/chemistry , Food Industry , Garbage , Kinetics , Methane/chemistry , Methanol/chemistry , Models, Statistical , Temperature
3.
Curr Hypertens Rep ; 17(4): 534, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25794952

ABSTRACT

This study aims to explore the relationship between currently recommended ambulatory blood pressure (ABP) measures used to classify pediatric hypertension and left ventricular mass index (LVMI) in children with true ambulatory hypertension. We performed a cross-sectional survey among 94 children who were consecutively referred for suspected hypertension. The calculated ABP measures were average 24-h systolic blood pressure (24-h aSBP) and 24-h SBP load. The LVMI was estimated by M-mode echocardiography using Devereux's formula and indexed by height(2,7). A total of 35 children fulfilled the criteria for true ambulatory hypertension (elevated office blood pressure, 24-h SBP load >25 %, and 24-h aSBP >95th percentile). Compared with children not fulfilling these criteria, those with true ambulatory hypertension had significantly higher values of 24-h aSBP, 24-h SBP load, and LVMI, as well as body mass index (BMI; P < 0.0001). In a separate analysis of both groups, none of the examined ABP measures adjusted for age, sex, and BMI correlated with LVMI. In those with true hypertension, only BMI was significantly associated with increased LVMI (F = 9.651; P = 0.004; adjusted R (2) = 0.203). The results of our study suggest that pediatric hypertension, as determined by currently recommended ABP (SBP) measures, is not associated with subclinical end-organ damage as defined by the increased left ventricular mass. Therefore, additional factors associated with BMI increase must be considered as risk factors for the development of end-organ damage in hypertensive children.


Subject(s)
Hypertension/physiopathology , Adolescent , Blood Pressure/physiology , Blood Pressure Monitoring, Ambulatory/methods , Body Mass Index , Cross-Sectional Studies , Echocardiography , Female , Humans , Male , Risk Factors , Systole
5.
Pediatr Crit Care Med ; 12(6): e402-3, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21116208

ABSTRACT

OBJECTIVE: Supraventricular paroxysmal tachycardias are the most common paroxysmal rhythm disorders in childhood. Atypical clinical presentations as well as their ability to induce hemodynamic deterioration imply necessity for arrhythmia rapid termination during the first months of life. The objective of this article was to evaluate the efficiency of deep nasopharyngeal aspiration as a potential vagal maneuver for supraventricular paroxysmal tachycardias termination. DESIGN: Clinical trial. PATIENTS AND METHODS: From June 2005 to October 2009, a total of eight infants, who were admitted at our institutions and diagnosed to have supraventricular paroxysmal tachycardias, were analyzed. To terminate supraventricular paroxysmal tachycardias "diving" reflex was initially tried and in the cases of its inefficacy, deep nasopharyngeal aspiration was performed. MAIN RESULTS: Nasopharyngeal aspiration successfully converted arrhythmia in three infants (37.5%). CONCLUSIONS: Deep nasopharyngeal aspiration could be an alternative vagal maneuver for infants with supraventricular paroxysmal tachycardia.


Subject(s)
Nasopharynx , Suction/methods , Tachycardia, Paroxysmal/therapy , Tachycardia, Supraventricular/therapy , Female , Humans , Infant , Male , Outcome Assessment, Health Care , Serbia
SELECTION OF CITATIONS
SEARCH DETAIL
...